FBLG FibroBiologics, Inc.
$0.93▼ -0.87%
Healthcare
Other
Volume 26.6K
Avg Volume (10D) 144.0K
Key Metrics & Fundamentals
Market Cap
$6.60M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.62 - 9.60
% vs 50 MA
-29.53%
% vs 200 MA
-62.29%
RSI-14
35.0
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.10
Free Cash Flow
-$3.29M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.95M
COGS
–
Operating Exp
$4.03M
Operating Income
-$4.03M
EBIT
-$4.03M
Pretax Income
-$4.12M
Net Income
-$4.12M
EPS (Diluted)
-0.66
Price & Volume History
Loading chart…
Recent News
FibroBiologics Presents Preclinical Data on Fibroblast Spheroid-Derived Chondrocyte Spheroids for Degenerative Disc Disease at the North American Spine Society 2026 Annual Meeting
PR Newswire · Oct 19, 2026 8:30 AM ET
FibroBiologics Announces Australian Patent Accepted for Cellular Blend for the Regeneration of Chondrocytes and Cartilage Cells in Degenerated Spinal Discs
PR Newswire · Oct 14, 2026 8:30 AM ET
FibroBiologics Files Patent Application for Technology Designed to Produce GLP-1 and Other Therapeutic Peptides Inside the Body
PR Newswire · Oct 7, 2026 8:30 AM ET
EXCLUSIVE: FibroBiologics Files Patent Application For Cell-Based Alternative to GLP-1 Injections
Benzinga · Oct 7, 2026 8:15 AM ET
FibroBiologics Announces Grant of European Patent for Methods of Enhancing Fibroblast Therapeutic Activity
PR Newswire · Sep 29, 2026 8:30 AM ET
Nova Minerals and FibroBiologics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
ACCESS Newswire · Sep 25, 2026 9:00 AM ET
FibroBiologics Announces Closing of $0.5 Million Private Placement with Chief Scientific Officer
PR Newswire · Sep 17, 2026 8:30 AM ET
Join FibroBiologics' Live Investor Webinar: Advancing a Fibroblast-Based Cell Therapy Platform Across Multiple High-Value Indications
ACCESS Newswire · Sep 8, 2026 9:00 AM ET
FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing
PR Newswire · Sep 3, 2026 8:30 AM ET
FibroBiologics Announces Issuance of New U.S. Patent for the Treatment of Degenerative Disc Disease Using Fibroblast Conditioned Media
PR Newswire · Sep 1, 2026 8:30 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See FBLG's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.